Farms.com Home   News

Flax Council Of Canada Looking To Develop New Opportunities

The Flax Council of Canada has been working on a new business plan.

Wayne Thompson, the Executive Director of Sask Flax, also serves as the Chief Executive Officer for FCC.

"We're working on our new business plan that focuses on market access issues to maintain the trade with the world and our customers. We have new customers that we're going to have to seek out as we continue to grow more flax and diversify our markets."

Thompson notes part of their new business plan is to encourage new memberships.

"We've got a core set of members that have been with the Flax Council of Canada for several years, but we want to broaden that membership. We do have a need to have more people around the table so we have a broader conversation and understand what other players that maybe aren't around the table right now are seeing and dealing with, so that we can benefit the industry in the broadest sense."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.